{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:05:03Z","timestamp":1793084703655,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["12649"],"award-info":[{"award-number":["12649"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijrobp.2023.09.016","type":"journal-article","created":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T20:08:54Z","timestamp":1695067734000},"page":"688-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prostate-Specific Membrane Antigen Positron Emission Tomography\/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2653-218X","authenticated-orcid":false,"given":"Floor H.E.","family":"Staal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorinde","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Oprea-Lager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine M.","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evert J.","family":"van Limbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Jan","family":"Smeenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne A.A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom C.G.","family":"Budiharto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien M.A.D.","family":"Haverkort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Ng Wei Siang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Fred","family":"Verzijlbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingle Jan","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Noordzij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafak","family":"Aluwini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.09.016_bib0001","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.urolonc.2006.06.003","article-title":"Pathologic findings at radical prostatectomy: Risk factors for failure and death","volume":"25","author":"Swanson","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0002","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1200\/JCO.2016.68.3425","article-title":"Improved metastasis-free and survival outcomes with early salvage radiotherapy in men with detectable prostate-specific antigen after prostatectomy for prostate cancer","volume":"34","author":"Stish","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0003","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":"Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0004","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2007.07.017","article-title":"Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group","volume":"84","author":"Poortmans","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0005","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ijrobp.2020.11.010","article-title":"Prostate bed delineation guidelines for postoperative radiation therapy: On behalf of the Francophone Group of Urological Radiation Therapy","volume":"109","author":"Robin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0006","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2008.05.006","article-title":"Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group","volume":"88","author":"Sidhom","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0007","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2007.04.068","article-title":"Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy","volume":"69","author":"Wiltshire","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0008","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ijrobp.2011.12.081","article-title":"Postoperative radiotherapy for prostate cancer: A comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT","volume":"84","author":"Malone","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0009","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijrobp.2013.06.2053","article-title":"Use of EORTC target definition guidelines for dose-intensified salvage radiation therapy for recurrent prostate cancer: Results of the quality assurance program of the randomized trial SAKK 09\/10","volume":"87","author":"Sassowsky","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijrobp.2021.12.174","article-title":"Adherence to contouring and treatment planning requirements within a multicentric trial: Results of the quality assurance of the SAKK 09\/10 trial","volume":"113","author":"Beck","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0011","article-title":"ESTROACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer","volume":"41","author":"Dal Pra","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0012","doi-asserted-by":"crossref","unstructured":"Staal FHE, Brouwer CL, Vanneste B, et al. A pre-trial quality assurance for salvage radiotherapy of the multi-institutional PERYTON-trial ESTRO 2021 presentation number: PO-1745. 2021. 28 - 31 August 2021, Madrid, Spain & Online Volume 161, Supplement 1, Pages S1467-S1468","DOI":"10.1016\/S0167-8140(21)08196-2"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0013","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12885-022-09493-5","article-title":"Phase III randomised controlled trial on PSMA PET\/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): Study protocol","volume":"22","author":"Staal","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.742093","article-title":"PET\/CT-based salvage radiotherapy for recurrent prostate cancer after radical prostatectomy: Impact on treatment management and future directions","volume":"11","author":"le Guevelou","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0015","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): A prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109631","article-title":"The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial","volume":"183","author":"Nikitas","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0017","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: The EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0018","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2307\/1932409","article-title":"Measures of the amount of ecologic association between species","volume":"26","author":"Dice","year":"1945","journal-title":"Ecology"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0019","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1109\/34.232073","article-title":"Comparing images using the Hausdorff distance","volume":"15","author":"Huttenlocher","year":"1993","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijrobp.2012.05.015","article-title":"Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging","volume":"85","author":"Liauw","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0021","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13014-015-0574-6","article-title":"Pelvic MRI findings in relapsed prostate cancer after radical prostatectomy","volume":"10","author":"Hernandez","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0022","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiol.2312030011","article-title":"Suspected local recurrence after radical prostatectomy: Endorectal coil MR imaging","volume":"231","author":"Sella","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0023","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/j.prro.2014.02.007","article-title":"Local recurrence map to guide target volume delineation after radical prostatectomy","volume":"4","author":"Wang","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0024","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0090-4295(99)80421-X","article-title":"Local recurrence after radical prostatectomy: Characteristics in size, location, and relationship to prostate-specific antigen and surgical margins","volume":"47","author":"Connolly","year":"1996","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0300891620908950","article-title":"Response on DCE-MRI predicts outcome of salvage radiotherapy for local recurrence after radical prostatectomy","volume":"107","author":"Sanguineti","year":"2021","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0026","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.eururo.2017.11.012","article-title":"Multiparametric magnetic resonance imaging is an independent predictor of salvage radiotherapy outcomes after radical prostatectomy","volume":"73","author":"Sharma","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0027","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/21681805.2015.1004643","article-title":"Role of 3T multiparametric magnetic resonance imaging without endorectal coil in the detection of local recurrent prostate cancer after radical prostatectomy: The radiation oncology point of view","volume":"49","author":"Cou\u00f1ago","year":"2015","journal-title":"Scand J Urol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0028","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2014.01.001","article-title":"Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy","volume":"110","author":"Park","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0029","doi-asserted-by":"crossref","first-page":"902","DOI":"10.2967\/jnumed.122.265025","article-title":"PSMA PET\/CT-based atlas for prostatic bed recurrence after radical prostatectomy: Clinical implications for salvage radiation therapy contouring guidelines","volume":"64","author":"Sonni","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0030","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijrobp.2022.05.044","article-title":"Mapping of local recurrences after radical prostatectomy using 68-gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography: Implications for postprostatectomy radiation therapy clinical target volumes","volume":"115","author":"Horsley","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0031","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ijrobp.2021.05.009","article-title":"Validating modern NRG oncology pelvic nodal and Groupe Francophone de Radiotherapie Urologique prostate bed contouring guidelines for post-prostatectomy salvage radiation: A secondary analysis of the LOCATE trial","volume":"111","author":"Harmon","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0032","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.euo.2022.04.002","article-title":"All prostate-specific membrane antigen peptides are equal, but some are more equal than others","volume":"5","author":"Emmett","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0033","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.euo.2022.03.004","article-title":"[(68)Ga]Ga-PSMA versus [(18)F]PSMA positron emission tomography\/computed tomography in the staging of primary and recurrent prostate cancer. A systematic review of the literature","volume":"5","author":"Evangelista","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0034","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","article-title":"Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in (68)Ga-PSMA-11-PET of PET\/CT and PET\/MRI: Comparison with mpMRI integrated in simultaneous PET\/MRI","volume":"44","author":"Freitag","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1148\/radiol.2020192018","article-title":"Evaluating biochemically recurrent prostate cancer: Histologic validation of (18)F-DCFPyL PET\/CT with comparison to multiparametric MRI","volume":"296","author":"Lindenberg","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0036","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2967\/jnumed.118.220103","volume":"60","author":"Emmett","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0037","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2967\/jnumed.117.196683","article-title":"Treatment outcomes from (68)Ga-PSMA PET\/CT-informed salvage radiation treatment in men with rising PSA after radical prostatectomy: Prognostic value of a negative PSMA PET","volume":"58","author":"Emmett","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2023.09.016_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109678","article-title":"Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study","volume":"184","author":"Scharl","year":"2023","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623079282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623079282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:11:00Z","timestamp":1759745460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623079282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0360301623079282"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.016","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate-Specific Membrane Antigen Positron Emission Tomography\/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}